In prostate cancer, inflammatory cytokines derived from the adjacent infiltrating CXCR6-positive T cells stimulate the production of CXCL16 by cancer cells and CXCL16 enhances the growth of CXCR6-expressing cancers and primary T cells (72). This evidence concerns the gene CXCR6 and prostate carcinoma.